Reclassified disease response criteria at 28 days of treatment for acute graft-vs-host disease (GVHD) improved prediction of 6-month nonrelapse mortality (NRM) compared with conventional criteria in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback